These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11256687)

  • 1. Does olanzapine have antidepressant properties? A retrospective preliminary study.
    Ghaemi SN; Cherry EL; Katzow JA; Goodwin FK
    Bipolar Disord; 2000 Sep; 2(3 Pt 1):196-9. PubMed ID: 11256687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine response in psychotic depression.
    Rothschild AJ; Bates KS; Boehringer KL; Syed A
    J Clin Psychiatry; 1999 Feb; 60(2):116-8. PubMed ID: 10084638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine in treatment-resistant bipolar disorder.
    McElroy SL; Frye M; Denicoff K; Altshuler L; Nolen W; Kupka R; Suppes T; Keck PE; Leverich GS; Kmetz GF; Post RM
    J Affect Disord; 1998 May; 49(2):119-22. PubMed ID: 9609675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of bipolar I disorder in an adolescent with olanzapine.
    Khouzam HR; El-Gabalawi F
    J Child Adolesc Psychopharmacol; 2000; 10(2):147-51. PubMed ID: 10933124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of olanzapine in the treatment of patients with psychotic depression.
    Nelson EB; Rielage E; Welge JA; Keck PE
    Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.
    Berk M; Ichim L; Brook S
    Int Clin Psychopharmacol; 1999 Nov; 14(6):339-43. PubMed ID: 10565800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bipolar mixed state with olanzapine.
    Sharma V; Pistor L
    J Psychiatry Neurosci; 1999 Jan; 24(1):40-4. PubMed ID: 9987206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of atypical antipsychotics in mood disorders.
    Weizman R; Weizman A
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of olanzapine in dysphoric mania.
    Gonzalez-Pinto A; Lalaguna B; Mosquera F; Pérez de Heredia JL; Gutierrez M; Ezcurra J; Gilaberte I; Tohen M
    J Affect Disord; 2001 Oct; 66(2-3):247-53. PubMed ID: 11578678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder.
    Vieta E; Reinares M; Corbella B; Benabarre A; Gilaberte I; Colom F; Martínez-Arán A; Gastó C; Tohen M
    J Clin Psychopharmacol; 2001 Oct; 21(5):469-73. PubMed ID: 11593070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.
    Gonzalez-Pinto A; Tohen M; Lalaguna B; Pérez-Heredia JL; Fernandez-Corres B; Gutierrez M; Micó JA
    J Clin Psychopharmacol; 2002 Oct; 22(5):450-4. PubMed ID: 12352266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.
    Janenawasin S; Wang PW; Lembke A; Schumacher M; Das B; Santosa CM; Mongkolcheep J; Ketter TA
    Bipolar Disord; 2002 Oct; 4(5):328-34. PubMed ID: 12479666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute dysphoric mania: treatment response to olanzapine versus placebo.
    Baker RW; Tohen M; Fawcett J; Risser RC; Schuh LM; Brown E; Stauffer VL; Shao L; Tollefson GD
    J Clin Psychopharmacol; 2003 Apr; 23(2):132-7. PubMed ID: 12640214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of olanzapine in non-psychotic psychiatric disorders.
    Goodnick PJ; Barrios CA
    Expert Opin Pharmacother; 2001 Apr; 2(4):667-80. PubMed ID: 11336615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturalistic study of olanzapine in treatment-resistant schizophrenia and acute mania, depression and obsessional disorder.
    Ohaeri JU
    East Afr Med J; 2000 Feb; 77(2):86-92. PubMed ID: 10774081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.